Connecting the dots...Provectus Biopharmaceuticals
Pages
(Move to ...)
Disclosures
The Blog
Current News
Archived News
Investment and Other Letters
Presentations
Blog Readership Statistics
About the Blogger
▼
Showing posts with label
$VICL
.
Show all posts
Showing posts with label
$VICL
.
Show all posts
May 16, 2013
$PVCT's PV-10 and $VICL's Allovectin-7
›
I know this comparison is spurious because apples are not being compared to apples. Nevertheless, it's interesting [at least to me] to...
May 4, 2013
@PropThinker's Undervaluation of Vical’s Full Pipeline Allows A Cheap Bet on Cancer Trial (and $PVCT)
›
PropThink provides actionable analysis of publicly-traded, emerging growth companies in the healthcare sector to retail and institutional i...
April 1, 2013
$PVCT: Understanding Why Cancer Vaccines Fail
›
This article from The Motley Fool is a nice read. The first part of the article revisits an MD Andersen discovery earlier this year that th...
›
Home
View web version
